A number of sources are attempting to provide consumers with usable information on provider costs and quality, which is a difficult task. HealthGrades, which is in that business, offers some information from an analysis of quality variations among hospitals. (HealthGrades Report) Using Medicare data and all-payer information in the states where it is available, the analysis reveals that within most geographies there does appear to be a substantial difference in outcomes which may be indicators of quality of care. For example in Denver, the complication rate for hip replacement procedures varied from 3.9% to 13.6%. According to the rating system HealthGrades uses, these differences are important for consumers to be aware of. On a 5 star rating system relating to outcomes, from 2012 to 2014, patients who received care at a 5 star hospital were 71% less likely to die and 65% less likely to have a complication than patients getting care at a one star facility. “Brand-name” hospitals in a region don’t always have the best ratings, so consumers should be wary of the marketing from these high-powered systems. And it can be hard to find a good facility by these measures, for example, in Chicago, only 2 out of 46 hospitals that do coronary artery bypass grafts have a 5 star rating. There is wide variation across various common conditions at the same facility as well, which means that consumers can’t assume that because a hospital has a five-star rating on one condition that it has good quality outcomes on others. As the analysis points out, consumers need to be directed toward a few meaningful outcomes that can be easily standardized across facilities and they need to get the information in an easy to understand format. The more consumers do these searches before getting care, the more likely poorer performing hospitals will feel pressure to improve.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
Commentary
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…
Commentary
March 24, 2023
A Couple of Health Care Notes
A couple of pieces of health care research focus on high health care spending and…